Healthcare & Life Sciences
64x Bio
Brisbane, United Stateswww.64xbio.com/
64x Bio is a series a startup based in United States. 3 investors tracked.
Activeseries-a
series-a
Stage
2018
Founded
1
Investors
About 64x Bio
64x Bio is a company founded in 2018 headquartered in Brisbane, the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Develops the VectorSelect cell-line platform and AAV, lentiviral and biologics Apex production suites for manufacturing advanced therapies.
Explore 64x Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.